|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-7-18
|
|
pubmed:abstractText |
The E5 oncoprotein of bovine papillomavirus type 1 is a 44-amino-acid, hydrophobic polypeptide which localizes predominantly in Golgi membranes and appears to transform cells through the activation of tyrosine kinase growth factor receptors. In fibroblasts, E5 interacts with both the 16-kilodalton vacuolar ATPase subunit and the platelet-derived growth factor receptor (PDGF-R) via its hydrophobic transmembrane domain and induces autophosphorylation of the receptor. To further analyze the correlation between E5 biological activity and its ability to bind these cellular proteins, a series of nine E5 transmembrane mutants was evaluated. In 32D mouse hematopoietic cells, there was an incomplete correlation between the abilities of the E5 mutant proteins to associate the PDGF-R and to transform cells. However, all transforming E5 mutant proteins induced PDGF-R tyrosine phosphorylation. In NIH 3T3 and C127 mouse fibroblasts, both transforming and nontransforming E5 mutant proteins were defective for PDGF-R binding. In addition, while most of the transforming E5 proteins induced PDGF-R phosphorylation, one hypertransforming mutant (serine 17) neither bound nor induced receptor autophosphorylation. These findings support the hypothesis that the transformation of fibroblasts by E5 transmembrane mutants can involve alternative cellular targets or potentially independent activities of the E5 protein. In addition, these results underscore the critical role of the transmembrane domain in mediating E5 biological activities.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-1370089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-1382297,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-1688529,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-1849073,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-1849139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2153303,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-219924,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2543792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2551505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2821369,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2847028,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-2885917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-3001335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-3006073,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-3006336,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-3014660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-3257584,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-6247821,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-6289064,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-6574462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7543592,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7621820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7666552,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7731695,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7739538,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-7896830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8057494,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8189497,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8207816,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8321218,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8394451,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8642670-8413245
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-538X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2420-30
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:8642670-3T3 Cells,
pubmed-meshheading:8642670-Adenosine Triphosphatases,
pubmed-meshheading:8642670-Amino Acid Sequence,
pubmed-meshheading:8642670-Animals,
pubmed-meshheading:8642670-Base Sequence,
pubmed-meshheading:8642670-Cell Transformation, Viral,
pubmed-meshheading:8642670-Glutamic Acid,
pubmed-meshheading:8642670-Golgi Apparatus,
pubmed-meshheading:8642670-Hematopoietic Stem Cells,
pubmed-meshheading:8642670-Lysine,
pubmed-meshheading:8642670-Mice,
pubmed-meshheading:8642670-Molecular Sequence Data,
pubmed-meshheading:8642670-Oncogene Proteins, Viral,
pubmed-meshheading:8642670-Phosphorylation,
pubmed-meshheading:8642670-Point Mutation,
pubmed-meshheading:8642670-Protein Binding,
pubmed-meshheading:8642670-Receptors, Platelet-Derived Growth Factor,
pubmed-meshheading:8642670-Serine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.
|
|
pubmed:affiliation |
Department of Pathology, Georgetown University Medical School, Washington, D.C. 20007, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
